| 2023-12-04 | Sale | Solid Biosciences Inc. SLDB | Chief Operating Officer | 5,367 0.0211% | $2.78 | $14,920 | +140.29% | |
| 2020-06-22 | Sale | Sarepta Therapeutics, Inc. SRPT | EVP, General Counsel | 105,122 0.1342% | $170.88 | $17.96M | -21.6% | |
| 2019-12-13 | Sale | Sarepta Therapeutics, Inc. SRPT | EVP, General Counsel | 78,000 0.097% | $125.50 | $9.79M | +4.3% | |
| 2019-11-22 | Sale | Sarepta Therapeutics, Inc. SRPT | EVP, General Counsel | 25,000 0.0321% | $105.00 | $2.63M | +25.6% | |
| 2019-02-01 | Sale | Sarepta Therapeutics, Inc. SRPT | SVP, General Counsel | 30,000 0.0419% | $140.00 | $4.2M | -13.46% | |
| 2018-07-16 | Sale | Sarepta Therapeutics, Inc. SRPT | SVP, General Counsel | 40,944 0.0575% | $127.18 | $5.21M | -8.11% | |
| 2017-07-20 | Sale | Sarepta Therapeutics, Inc. SRPT | SVP, General Counsel | 5,944 0.0097% | $41.00 | $243,704 | +46.25% | |
| 2016-09-22 | Sale | Sarepta Therapeutics, Inc. SRPT | SVP, General Counsel | 7,000 0.0143% | $60.00 | $420,000 | -43.78% | |
| 2016-09-19 | Sale | Sarepta Therapeutics, Inc. SRPT | SVP, General Counsel | 9,304 0.0197% | $50.00 | $465,200 | -29.97% | |
| 2011-09-01 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP | 328 0.0002% | $44.29 | $14,527 | -8.66% |